MNIVF
Monash IVF Group Limited engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Richmond, Au… Read more
MNIVF (MNIVF) - Total Assets
Latest total assets as of June 2024: $516.65 Million USD
Based on the latest financial reports, MNIVF (MNIVF) holds total assets worth $516.65 Million USD as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
MNIVF - Total Assets Trend (2021–2024)
This chart illustrates how MNIVF’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
MNIVF - Asset Composition Analysis
Current Asset Composition (June 2024)
MNIVF's total assets of $516.65 Million consist of 11.0% current assets and 89.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.2% |
| Accounts Receivable | $6.22 Million | 1.2% |
| Inventory | $8.18 Million | 1.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $23.97 Million | 4.7% |
| Goodwill | $273.35 Million | 53.8% |
Asset Composition Trend (2021–2024)
This chart illustrates how MNIVF's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MNIVF's current assets represent 11.0% of total assets in 2024, an increase from 6.4% in 2021.
- Cash Position: Cash and equivalents constituted 2.2% of total assets in 2024, down from 2.5% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 57.0% of total assets, a decrease from 73.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 53.8% of total assets.
MNIVF Competitors by Total Assets
Key competitors of MNIVF based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
MNIVF - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - MNIVF generates 0.50x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - MNIVF is currently not profitable relative to its asset base.
MNIVF - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.54 | 0.64 | - |
| Quick Ratio | 0.40 | 0.51 | - |
| Cash Ratio | 0.00 | 0.00 | - |
| Working Capital | $-54.86 Million | $ -16.57 Million | - |
MNIVF - Advanced Valuation Insights
This section examines the relationship between MNIVF's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.97 |
| Latest Market Cap to Assets Ratio | 0.31 |
| Asset Growth Rate (YoY) | 20.5% |
| Total Assets | $508.47 Million |
| Market Capitalization | $155.85 Million USD |
Valuation Analysis
Below Book Valuation: The market values MNIVF's assets below their book value (0.31 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: MNIVF's assets grew by 20.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for MNIVF (2021–2024)
The table below shows the annual total assets of MNIVF from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-06-30 | $508.47 Million | +20.52% |
| 2023-06-30 | $421.89 Million | +10.79% |
| 2022-06-30 | $380.82 Million | +8.44% |
| 2021-06-30 | $351.17 Million | -- |